C18.6 Malignant neoplasm, descending colon - analogs
| Description «C18.6 Malignant neoplasm, descending colon» | ||||||
|
||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 40% Compare C18.2 Malignant neoplasm, ascending colon
- 40% Compare C18.4 Malignant neoplasm, transverse colon
- 40% Compare C18 Malignant neoplasm of colon
- 24% Compare C18.7 Malignant neoplasm, sigmoid colon
- 24% Compare C19 Malignant neoplasm of rectosigmoid junction
- 24% Compare C21.1 Malignant neoplasm, anal canal
- 24% Compare C20 Malignant neoplasm of rectum
- 24% Compare C21 Malignant neoplasm of anus and anal canal
- 24% Compare C21.8 Malignant neoplasm, overlapping lesion of rectum, anus and anal canal
- 23% Compare D01.4 Carcinoma in situ, other and unspecified parts of intestine
- 20% Compare C17.9 Malignant neoplasm, small intestine, unspecified
- 20% Compare D12 Benign neoplasm of colon, rectum, anus and anal canal
- 20% Compare C21.0 Malignant neoplasm, anus, unspecified
- 20% Compare C78.5 Secondary malignant neoplasm of large intestine and rectum
- 17% Compare C78.4 Secondary malignant neoplasm of small intestine
- 15% Compare D12.6 Benign neoplasm, colon, unspecified
- 13% Compare K63.5 Polyp of colon
- 10% Compare C52 Malignant neoplasm of vagina
- 10% Compare D14.3 Benign neoplasm, bronchus and lung
- 10% Compare C78.7 Secondary malignant neoplasm of liver and intrahepatic bile duct
- 10% Compare C93.0 Acute monoblastic/monocytic leukaemia
- 10% Compare C78.0 Secondary malignant neoplasm of lung
- 10% Compare C92.5 Acute myelomonocytic leukaemia
- 10% Compare C40.3 Malignant neoplasm, short bones of lower limb
- 10% Compare C62.1 Malignant neoplasm, descended testis
- 10% Compare C95.0 Acute leukaemia of unspecified cell type
- 10% Compare C92.4 Acute promyelocytic leukaemia [PML]
- 10% Compare C94 Other leukaemias of specified cell type
- 10% Compare C94.2 Acute megakaryoblastic leukaemia
- 10% Compare C40.0 Malignant neoplasm, scapula and long bones of upper limb
- 10% Compare C62 Malignant neoplasm of testis
- 10% Compare D13 Benign neoplasm of other and ill-defined parts of digestive system
- 10% Compare C41.1 Malignant neoplasm, mandible
- 10% Compare C40.2 Malignant neoplasm, long bones of lower limb
- 10% Compare D37.6 Neoplasm of uncertain or unknown behaviour, liver, gallbladder and bile ducts
- 10% Compare C78.1 Secondary malignant neoplasm of mediastinum
- 10% Compare C40.1 Malignant neoplasm, short bones of upper limb
- 10% Compare C79.7 Secondary malignant neoplasm of adrenal gland
- 10% Compare C08.0 Malignant neoplasm, submandibular gland
- 10% Compare C95 Leukaemia of unspecified cell type
- 10% Compare C76.0 Malignant neoplasm, head, face and neck
- 10% Compare C41.8 Malignant neoplasm, overlapping lesion of bone and articular cartilage
- 10% Compare C15.1 Malignant neoplasm, thoracic part of oesophagus
- 10% Compare C79.0 Secondary malignant neoplasm of kidney and renal pelvis
- 10% Compare C13.2 Malignant neoplasm, posterior wall of hypopharynx
- 10% Compare C70.1 Malignant neoplasm, spinal meninges
- 10% Compare C22 Malignant neoplasm of liver and intrahepatic bile ducts
- 10% Compare D00 Carcinoma in situ of oral cavity, oesophagus and stomach
- 10% Compare C77.8 Secondary and unspecified malignant neoplasm, lymph nodes of multiple regions
- 10% Compare C77.9 Secondary and unspecified malignant neoplasm, lymph node, unspecified
Learn more about the selection of analogues
- Medical online service designed to help in differential diagnosis.
- Find similar diseases for a diagnosis that causes irritation.
- If you are a professional, then the help of artificial intelligence will help in the express diagnostics.
The advantage of Kiberis is its versatility, thanks to which it is able to select analogues for anything, including for diseases and diagnoses. Artificial intelligence analyzes descriptions of diseases, clinical recommendations for their treatment, real statistics on making diagnoses and displays the most similar diseases with a degree of similarity in percent.